肾脏嗜酸细胞腺瘤与嫌色细胞癌的临床及MSCT分析  

Clinical and MSCT analysis of renal oncocytoma and chromophobe cell carcinoma

作　　者：李俊 邵国良[1,2] Li Jun;Shao Guoliang(Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang 310022,China;Institute of Cancer and Basic Medicine(IBMC),Chinese Academy of Sciences,Hangzhou,Zhejiang 310022,China)

机构地区：[1]中国科学院大学附属肿瘤医院<浙江省肿瘤医院>,浙江杭州310022 [2]中国科学院肿瘤与基础医学研究所,浙江杭州310022

出　　处：《影像研究与医学应用》2020年第13期28-30,共3页Journal of Imaging Research and Medical Applications

摘　　要：目的:探讨肾脏嗜酸细胞腺瘤(RO)与嫌色细胞癌(CCRC1)的临床特点及MSCT多期增强特点。方法:收集经术后病理证实的10例RO和18例CCRC患者,分析两者的临床特点及MSCT多期增强后的影像特征。结果:MSCT多期增强扫描RO强化程度在各期均高于CCRC,其中实质期及排泄期具有统计学差异(P<0.05)。结论:RO和CCRC的临床特点及一般MSCT表现具有重叠性,MSCT多期增强扫描有利于两者之间的鉴别诊断。Objective To investigate the clinical characteristics of renal oncocytoma(RO)and chromophobe cell carcinoma(CCRC)and the multiphase enhancement of MSCT.Methods 10 cases of RO and 18 cases of CCRC confirmed by postoperative pathology were collected to analyze their clinical characteristics and the imaging characteristics after MSCT multi-phase enhancement.Results The degree of RO enhancement in MSCT multiphase enhanced scan was higher than that of CCRC in each phase,and there was significant difference between the parenchyma phase and the excretion phase(P<0.05).Conclusion The clinical features of RO and CCRC and the general manifestations of MSCT are overlapped.MSCT multi-phase enhanced scan is conducive to the differential diagnosis between them.

关 键 词：嗜酸细胞腺瘤 嫌色细胞癌 

分 类 号：R737.11[医药卫生—肿瘤]